Interpharma and the British-Swiss Chamber of Commerce enter into a partnership. Important topics for the Life Science hubs Switzerland and United Kingdom will be discussed during BSCC Life Science Club events. In Switzerland, pharmaceutical products account for 44% of total exports (2020), while in the UK, the pharmaceutical industry is the second most important exporter of goods. The two countries are of great importance both for Europe and in direct trade. The partnership will offer BSCC and Interpharma members the opportunity for exchange and networking across organisational borders.
Interpharma, the association of Switzerland’s research-based pharmaceutical industry, informs the public about issues that are important to the industry in Switzerland, including the pharma market in Switzerland, healthcare and biomedical research.
The British-Swiss Chamber of Commerce (BSCC) is an independent not-for-profit organisation dedicated to supporting over 500 members in Switzerland, Liechtenstein and the UK. The BSCC helps businesses grow by promoting bilateral trade, business and investment opportunities and providing a platform for business people to engage in dialogue and facilitate change.
Interpharma, the association of Switzerland’s research-based pharmaceutical industry, was founded in Basel in 1933.
Interpharma informs the public about issues that are important to the research-based pharmaceutical industry in Switzerland, including the pharma market in Switzerland, healthcare and biomedical research.
Information on our key figures and activities in the financial year 2022
More about the tasks and overriding aims of Interpharma
Latest information and media contacts for media representatives